NSE filing, NSE: JLHL. Summary written from the filing by ALFA Finder's alert engine.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹263.60
- Market cap
- ₹8,642 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 46.4×Sector 53.7×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Other capital structure change announcements
All →Shree Pushkar Chemicals & Fertilisers Capital Structure Change
Shree Pushkar Chemicals' board approved reissue of forfeited shares and fund raising. Authorised capital rises to 34 million shares, subject to a 2 December 2026 vote.
Lloyds Engineering Works Capital Structure Change
Lloyds Engineering Works will invest Rs 100 Crore in subsidiary Steel Infra Solutions via preferential share subscription. Payment comes in two Rs 50 Crore tranches.
- Value
- ₹100.0 Cr
- Execution
- Whole transaction to complete within 18 months
Ola Electric Mobility Capital Structure Change
Ola Electric allotted equity shares under a rights issue, raising paid-up capital from Rs.4,628.41 Crore to Rs.4,850.57 Crore. Post-allotment shares total 49,98,68,978.
- Value
- ₹222.2 Cr
Ola Electric Mobility Capital Structure Change
Ola Electric allotted 37,02,72,665 partly paid-up rights shares at Rs 16.20 each, about Rs 599.84 Crore on application. Balance call money remains payable.
- Value
- ₹599.8 Cr
Mihika Industries Capital Structure Change
Mihika Industries fixed terms for a ₹90 crore partly paid rights issue. Record date is November 6, 2026, at 9 rights shares per share held.
- Value
- ₹90.00 Cr
Swelect Energy Systems Capital Structure Change
SWELECT approved up to Rs 4.36 crore equity infusion into its wholly owned subsidiary. The funds will develop a 4.5 MWp group captive solar plant in Kerala.
- Value
- ₹4.36 Cr
- Execution
- Multiple tranches per the investee company's offer letter
- solar capacity (DC)
- 4.5 MW